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NAD+ plays central roles in energy metabolism as redox carrier. Recent research has identiﬁed
important signalling functions of NAD+ that involve its consumption. Although NAD+ is synthesized
mainly in the cytosol, nucleus and mitochondria, it has been detected also in vesicular and extracel-
lular compartments. Three protein families that consume NAD+ in signalling reactions have been
characterized on a molecular level: ADP-ribosyltransferases (ARTs), Sirtuins (SIRTs), and NAD+ glyco-
hydrolases (NADases). Members of these families serve important regulatory functions in various
cellular compartments, e.g., by linking the cellular energy state to gene expression in the nucleus,
by regulating nitrogen metabolism in mitochondria, and by sensing tissue damage in the extracel-
lular compartment. Distinct NAD+ pools may be crucial for these processes. Here, we review the cur-
rent knowledge about the compartmentation and biochemistry of NAD+-converting enzymes that
control NAD+ signalling.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The variety of physiological roles played by NAD+ has long been
underestimated. Besides its vital functions as electron carrier, this
pyridine nucleotide has important functions in signalling pathways
[1–4]. The expression of several genes is linked to the redox state of
pyridine nucleotides via NAD+/NADH-binding proteins that act as
redox sensors [5,6]. NAD+ also mediates post-translational protein
modiﬁcations such as ADP-ribosylation and NAD+-dependent pro-
tein deacetylation [7–13]. Moreover, it is a direct precursor of mes-
senger molecules such as ADP-ribose (ADPR), cyclic ADP-ribose
(cADPR) and O-acetyl-ADP-ribose (OAADPR), which are all in-
volved in intracellular Ca2+ mobilization [14–16]. NAD+-mediated
signalling has now moved into focus as it governs fundamental
biological processes both on a cellular and organismal level. To ful-
ﬁl such a broad range of functions a variety of mechanisms leading
to signalling conversions of NAD+ have evolved. Several enzymes
have been identiﬁed that catalyse different conversions of NAD+
leading to highly speciﬁc or rather general physiological conse-
quences. This multitude of different signalling pathways requires
precise spatial organization. Several excellent recent reviews have
covered various aspects of NAD signalling [1–16]. This review fo-chemical Societies. Published by E
Koch-Nolte).
thias.Ziegler@mbi.uib.no (M.cuses on the biochemistry and compartmentation of NAD+-con-
verting enzymes and of NAD+ itself in mammalian cells.
2. Conversions of NAD+ in signalling reactions
In redox reactions, NAD+ is reversibly converted to NADH by
addition of two electrons and a proton to the nicotinamide ring,
thereby oxidizing metabolic intermediates (Fig. 1). In contrast,
NAD+-dependent signalling reactions involve cleavage of the glyco-
sidic bond between nicotinamide and ADP-ribose (wavy red line in
Fig. 1), i.e. the consumption of NAD+. These reactions result in the
transfer of the ADP-ribose moiety onto an acceptor, and release of
the remaining nicotinamide. Therefore, these reactions are also re-
ferred to as ADP-ribosyl transfer.
2.1. NAD+-dependent protein modiﬁcation and generation of second
messengers
There are two principal types of NAD+-dependent signalling
reactions, the modiﬁcation of proteins and the generation of mes-
senger molecules (Fig. 1). NAD+-dependent protein modiﬁcations
include ADP-ribosylation reactions, that is, covalent attachment
of ADP-ribose to speciﬁc amino acid residues, and the deacetyla-
tion of lysine residues, catalysed by ADP-ribosyltransferases (ARTs)
and sirtuins (SIRTs), respectively. ADP-ribosylation and deacetyla-
tion activate or inactivate target protein functions, as in the case of
other posttranslational protein modiﬁcations. ADP-ribosylation is alsevier B.V. All rights reserved.
Fig. 1. NAD+-converting enzymes and NAD+-dependent signalling. In redox reactions, NAD+ is reversibly converted to NADH by addition of two electrons and a proton to the
nicotinamide ring. NAD+-converting enzymes cleave the glycosidic bond in NAD+ linking nicotinamide to ribose (indicated by the red wave). ADP-ribosyltransferases (ART)
transfer ADPR onto amino acid residues (mono-ADP-ribosylation) or onto protein-linked ADP-ribose moieties (poly ADP-ribosylation). These protein modiﬁcations are
reversed by ADP-ribosylhydrolases (ARH) and poly-ADP-ribosyl-glycohydrolase (PARG), liberating ADPR. Sirtuins (SIRT) catalyse NAD+-dependent deacetylation of proteins
carrying acetylated lysine residues, yielding O-acetyl-ADPR (OAADPR). NAD-glycohydrolases (NADase) catalyse hydrolysis of NAD+ to ADPR and nicotinamide and cyclisation
of ADPR to cyclic-ADPR. NADases also catalyse substitution of the nicotinamide moiety in NADP+ by nicotinic acid, yielding NAADP. These NAD+-derivatives can trigger
elevation of intracellular Ca2+.
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cation, two modes can be distinguished, mono-ADP-ribosylation
and poly-ADP-ribosylation. ADP-ribose is released from mono- or
poly-ADP-ribosylated proteins by ADP-ribosylhydrolases (ARHs)
and poly-ADP-ribose glycohydrolase (PARG) [10]. NAD+-dependent
protein deacetylation involves transfer of the acetyl group from the
target protein onto ADP-ribose resulting in the formation of O-
acetylated ADP-ribose [12]. Both ADPR and OAADPR have been
implicated as second messengers. Second messengers can also be
generated from NAD+ by ADP-ribosylcyclases/NAD+ glycohydrolas-
es (NADases), yielding ADPR and cADPR [14]. NADases also cata-
lyse the substitution of the nicotinamide moiety by nicotinic acid
in NADP (generated from NAD+ by NAD kinase), thereby forming
nicotinic acid adenine dinucleotide phosphate (NAADP). All these
NAD+-derived second messengers contribute to intracellular cal-
cium signalling by acting on calcium channels in the plasma mem-
brane, endoplasmatic reticulum or lysosomes.
2.2. Three NAD+-converting protein families
In enzymes catalysing redox reactions the adenine and pyridine
moieties of NAD+/NADH typically each are bound by a separate
classic Rossmann/Walker nucleotide-binding fold. The CtBP family
of redox-responsive transcription factors similarly binds NAD+/
NADH with two separate Rossman fold [17]. The enzymes catalys-
ing NAD+-consumption fall into three individual protein families
containing distinct NAD+-binding domains. SIRTs use a single copy
of the Rossman fold for coordinating the adenine moiety of NAD+
[18,19]. ARTs and NADases carry rather distinct NAD+-binding
domains.
ARTs bind NAD+ in an extended conformation in a Pacman-like
crevice formed by two abutting b-sheets [20,21]. Nicotinamide is
buried in a deep pocket, exposing the glycosidic bond between nic-
otinamide and the adjacent ribose moiety for nucleophilic attack
by a variety of substrates, including amino acids, nucleotides,
ADP-ribose, phosphate, antibiotics, and water. Mammals use the
ART family mainly for posttranslational ADP-ribosylation of amino
acid residues in proteins and for the ADP-ribosylation of protein-linked ADP-ribose moieties, generating polymers of ADP-ribose
(PARsylation) [11]. One member of the ART family catalyses trans-
fer of ADP-ribose to the terminal phosphate in t-RNA, initiating the
splicing reaction and the release of ADP-ribose 10–20 cyclic phos-
phate [22,23]. The ART fold has been found in proteins from all
kingdoms of life. In mammals, the ART family is the largest and,
perhaps, most versatile of the three NAD+-converting protein fam-
ilies [10]. The 20–25 members of the ART family can be subdivided
into two structurally distinct subclasses designated ARTC and
ARTD on the basis of structural similarities to cholera and diphthe-
ria toxins, respectively [11]. Members of the smaller ARTC subfam-
ily are expressed as GPI-anchored or secreted ecto-enzymes.
Members of the larger ARTD subfamily include nuclear poly-
ADP-ribosyltransferases, the t-RNA dephosophorylating enzyme
TpT, and cytosolic oligo- and mono-ADP-ribosyltransferases.
SIRTs have a low intrinsic NAD+ binding afﬁnity, and NAD+-
binding to SIRTs generally requires prior binding of an acetylated
peptide [18,19]. This peptide forms the central strand of a three-
stranded enzyme-substrate b-sheet in a crevice between the small
Zn-binding domain and the large Rossman nucleotide-binding fold.
NAD+ binds in an extended conformation that exposes the alpha
face of the nicotinamide ribose to the carbonyl oxygen of the acetyl
lysine substrate promoting formation of an O-alkylamidate reac-
tion intermediate, the deacetylation of lysine and the release of
O-acetyl ADP-ribose. The SIRT fold has been found in proteins from
all kingdoms of life [24,25]. The seven members of the mammalian
Sirtuin family are located in the nucleus, cytosol, and mitochondria
[24].
NADases bind NAD+ in a bent conformation [26,27]. These en-
zymes facilitate base-exchange of the nicotinamide moiety, intra-
molecular cyclisation or hydrolysis of the high energy bond. The
NADase fold has been identiﬁed so far only in proteins of metazoan
animals [16]. In mammals, the two members of the ADP-ribosylcy-
clase/NADase family are expressed as membrane bound ecto-
enzymes [16,28].
Some members of these protein families show overlapping
enzyme activities, e.g., hydrolysis of NAD+ by some ARTs and the
ADP-ribosylation of proteins by some SIRTs.
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Over the last years, important discoveries have been made with
regard to all the signalling conversions mediated by NAD+. Never-
theless, NAD+-dependent protein deacetylation by SIRT1 has run
the show lately, because its activity has been associated with a
number of fundamental biological processes, most prominently
regulation of the circadian clock and ageing [12,24,25]. SIRT1
deacetylates histones at speciﬁc gene loci and thereby silences
expression of the corresponding genes. Accordingly, activation of
the SIRT1 homologues in non-mammalian species such as yeast,
Caenorhabditis elegans or ﬂies leads to substantial extension of life
span. In mammals, SIRT1 has been shown to regulate the activity of
important transcription factors such as p53, PGC1a, Forkhead-box
proteins and others. Thereby, its activity affects metabolic homeo-
stasis, participates in the regulation of the biological clock, and in-
creases stress resistance. Moreover, sirtuins regulate the activity of
key metabolic enzymes. In most cases, the deacetylation leads to
catalytic activation of the target proteins.
The ART family also has a broad scope of regulatory functions,
ranging from DNA repair to sensing cell death in inﬂammation
[1,10,11]. Poly-ADP-ribosylation has largely been associated with
nuclear events [9]. The most prominent enzyme, referred to as
poly-ADP-ribose polymerase 1 (PARP1) or ARTD1 [11], has a criti-
cal function in DNA repair, based on its high afﬁnity to DNA lesions.
Under normal physiological conditions PARP1 is rather inactive,
whereas its binding to DNA strand breaks dramatically increases
its catalytic activity. Thereby, the site of DNA damage is ‘‘marked’’
with polymers of ADP-ribose, which facilitates the recruitment of
DNA repair factors. PARP1 also participates in the regulation of
transcription, the regulation of chromatin structure and other nu-
clear processes related to DNA rearrangements [9,29]. Following
the release of NAD+ from cells during inﬂammation, ARTs tethered
to the extracellular leaﬂet of the plasma membrane ADP-ribosylate
the ectodomains of numerous cell surface proteins, and secretory
ARTs ADP-ribosylate inﬂammatory cytokines [8]. These extracellu-
lar ADP-ribosylation reactions play important regulatory roles in
cellular communication and immune cell homeostasis [30,31].Fig. 2. Compartmentation of NAD+ and NAD+-converting enzymes. In mammals, NAD+-c
nucleus and mitochondria. The concentration of NAD+ is high in mitochondria (400
extracellular space, and can vary considerably depending on the cell type, metabolic
compartments including the endoplasmic reticulum, the Golgi apparatus, exocytotic vesi
difﬁcult to assess experimentally (indicated in grey).Second messenger molecules generated during NAD+-depen-
dent protein modiﬁcations or directly from NAD+ or NADP+ by
NADases trigger the release of calcium from intracellular stores
or entry of calcium through plasma membrane channels [14,15].
Cyclic ADP-ribose activates the ryanodine receptor leading to the
release of calcium from the endoplasmic reticulum, similar to ino-
sitol-1,4,5-trisphosphate (IP3), which activates the IP3 receptor. In
addition, cADPR is a ligand of the TRPM2 channel (a member of the
transient receptor potential cation channel family) and thereby
stimulates the inﬂux of calcium from the extracellular space. Both
ADPR and OAADPR have also been reported to activate TRPM2
channels. NAADP releases calcium from intracellular, possibly cell
type-speciﬁc stores by activating lysosomal calcium channels and
the ryanodine receptor [32–35]. The capacity of NAD+-derived
messengers, in addition to IP3, to selectively trigger calcium re-
lease into the cytosol may provide mechanisms to conﬁne calcium
signalling in time and space and to allow calcium signalling by spe-
ciﬁc mechanisms in response to different extracellular signals.3. Compartmentation of NAD+-dependent signalling pathways
Given the variety of NAD+-degrading processes and subsets of
enzymes competing for the same substrate, NAD+-dependent reg-
ulatory pathways need to be tightly regulated, e.g., by speciﬁc up-
stream mechanisms that govern the activation or inhibition of
individual NAD+-dependent mechanisms [3,4]. Moreover, NAD+-
dependent signalling pathways are compartmentalized, providing
another level of regulation and sophistication. Fig. 2 depicts the
cellular distribution of known enzyme activities contributing to
NAD+-dependent regulatory pathways and illustrates estimated
concentrations of NAD+ in different cellular compartments [4].
Interestingly, a number of NAD+-dependent regulatory reactions
take place on the outer surface of the plasma membrane, despite
the rather low concentration of NAD+ (submicromolar) in extracel-
lular ﬂuids, e.g., serum [2]. Below, we provide a few examples of
NAD+-mediated signalling processes that take place in different
subcellular compartments and on the cell surface.onverting enzymes have been identiﬁed in the extracellular space, the cytosol, the
lM), intermediate in the nucleus and cytosol (100 lM) and low (<1 lM) in the
condition, stress, and redox status. Mounting evidence indicates that vesicular
cles and peroxisomes also harbour NAD+, albeit at concentrations that are extremely
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The plasmamembrane is impermeable to NAD+. However, NAD+
is released from cells by lytic and non-lytic mechanisms following
disruption of membrane integrity by pore forming proteins,
mechanical injury or osmotic forces [30,36]. Unless repaired, large
or enduring leaks in the cell membrane cause breakdown of the
electrochemical potential and cell death. The leakage of NAD+ from
dying cells may represent an ancient danger signal and a universal
‘‘molecular odorant’’ of dead cells. Lysis of cells in multicellular
organisms often accompanies infections by microbial pathogens,
e.g., during infection of cells with a lytic virus, puncture of the cell
membrane by bacterial haemolysins and other microbial or endog-
enous pore-forming proteins, e.g., complement factors or perforins
secreted by cytotoxic T cells and natural killer cells. It is perhaps
not surprising, then, that metazoan immune cells have developed
sensors for NAD+ and its metabolites in the form of ecto-enzymes,
ligand-gated ion channels, and G-protein-coupled receptors
(GPCRs) [8,28,37].
Several members of the ART family are expressed on the outer
leaﬂet of the plasma membrane as GPI-anchored ecto-enzymes
or as secretory proteins. In response to NAD+ released from cells,
these enzymes ADP-ribosylate other cell surface and secretory pro-
teins. This provides a mechanism of translating pulses of leaked
NAD+ into longer-lasting imprints [31,36]. The ADP-ribosylation
of human neutrophil peptide 1 on Arg14 and Arg24 by ARTC1
and the ADP-ribosylation of the P2X7 ion channel on Arg125 and
Arg133 by ARTC2 provide well-characterized examples of cell sur-
face and secretory proteins regulated by ADP-ribosylation [8,38–
40].
NAD+ hydrolysis by CD38, a member of the NADase family teth-
ered to the cell surface, is an important mechanism to limit the
duration of NAD+-signalling in the extracellular compartment
[41]. Moreover, this enzyme generates potent calcium-mobilizing
second messengers, e.g., ADP-ribose and cyclic ADP-ribose.
Whether and how these messengers enter the cells to elevate the
cytosolic calcium remains unknown. However, on the cell surface
they are also further catabolised by extracellular pyrophospha-
tase/phosphodiesterases (ENPP, CD203) and 50 nucleotidase (ENT,
CD73) [42], thereby generating AMP and adenosine, which can
activate members of the P2Y and P1 subfamilies of GPCRs. The
metabolites adenosine, nicotinamide, and phosphate can be taken
up by cells and used for the regeneration of NAD+ [42].
Dying cells also release cytosolic enzymes. Serum levels of cre-
atine kinase and amino-acid transferases, for example are used as
indicators of muscle and liver damage, respectively. Some cytosolic
enzymes involved in NAD+-signalling have also been detected in
serum: serum levels of adenosine deaminase (ADA), the enzyme
catalysing conversion of adenosine into inosine, increase in rheu-
matoid arthritis and other chronic inﬂammatory diseases [43].
NAMPT, the enzyme catalysing the rate-limiting step in NAD+ syn-
thesis, reportedly functions also as a cytokine acting on B cells and
neutrophils [44,45] and as an adipocytokine [46]. It is conceivable,
though not established, that other intracellular enzymes involved
in NAD+-signalling might be released from cells in enzymatically
active form. However, the pathophysiological interplay of bona-
ﬁde extracellular NAD+-metabolising enzymes such as ART2 and
CD38 and released cytosolic enzymes such as NAMPT and ADA still
need to be explored.
Apart from the lytic release of NAD+ from injured or dying cells,
mounting evidence indicates that NAD+ can also be released from
cells in a regulated fashion, e.g., by reversible opening of pores
formed by members of the gap-junction protein family, e.g., Conn-
exin 43 and Pannexin 1, or by vesicular exocytosis [47]. NAD+
reportedly is released from motor nerve terminals upon electrical
stimulation and may act as a neurotransmitter on purinergicGPCRs expressed by smooth muscle cells in blood vessels, the kid-
ney and the gut [48,49].
3.2. Nuclear NAD+-dependent signalling
Prominent NAD+-dependent processes in the nucleus include
poly-ADP-ribosylation and protein deacetylation. Besides PARP1
(ARTD1), other ARTs generating protein-bound PAR play important
roles. PARP2 (ARTD2), even though catalytically less active, appears
to facilitate DNA repair, similar to, or in concert with PARP1. Poly-
ADP-ribosylation is also involved in the regulation of telomerase
activity. The telomeric repeat binding factor 1 (TRF1) prevents ac-
cess of telomerase to telomers by binding to the telomeric DNA.
When activated, the ART enzyme tankyrase 1 (ARTD5) catalyses
poly-ADP-ribosylation of TRF1. Thereby, TRF1 loses its DNA bind-
ing ability and telomerase gains access to extend telomers. PARP1
can modulate transcription in a similar fashion by modifying spe-
ciﬁc transcription factors that become unable to bind to their cog-
nate sites in the DNA. PARG activity in the nucleus rapidly
degrades PAR, making poly-ADP-ribosylation a rather transient
modiﬁcation.
The best studied nuclear sirtuin is SIRT1. Numerous studies
have documented that SIRT1 deacetylates not only histones, but
also critical transcription factors. Among the consequences of
SIRT1-mediated transcriptional regulation is the favourable adjust-
ment of energy metabolism. In this regard, among the major tar-
gets of SIRT1 deacetylation are PGC1a, PPARc and FOXO
transcription factors. Therapeutic concepts, based on SIRT1 activa-
tion, begin to emerge which are designed to counteract, for exam-
ple, diet-induced obesity, obesity-induced diabetes and metabolic
syndrome [50]. Another example as to how SIRT1 activity modu-
lates the function of an organism as a whole was provided by its
identiﬁcation as an important regulator of the biological clock. It
has been proposed that, at least in metabolically active tissues,
SIRT1 may act as a ‘‘rheostat’’ within the clock system and deter-
mine the epigenetic regulation of the clock system through
NAD+-dependent deacetylation [51].
SIRT2 has been observed to reside both in the nucleus and the
cytosol. Besides histones, it targets p300, a crucial protein acety-
lase. Interestingly, SIRT2 and p300 interact reciprocally. That is,
p300 acetylates SIRT2, while SIRT2 deacetylates p300.
3.3. Cytosolic NAD+-dependent signalling
ADP-ribosylation of elongation factor 2, actin, rho, and Ga, cat-
alysed by bacterial toxins that translocate into the cytosol of mam-
malian cells, profoundly perturb cellular functions, causing severe
diseases including diphtheria, whooping cough and cholera
[52,53]. These toxins may mimic endogenous regulatory processes,
and biochemical studies, indeed, have detected similar enzyme
activities in various tissues [54]. However, the corresponding cyto-
solic proteins have so far eluded molecular characterisation. An-
other intriguing example of cytosolic ADP-ribosylation is the
activity of vault-PARP (ARTD6): this enzyme catalyses reversible
oligo-ADP-ribosylation of the major vault protein, the main struc-
tural component of a huge cytosolic ribonucleoprotein complex
thought to be involved in mRNA transport [55]. Characterisation
of cytosolic ADP-ribosylation reactions is hampered by the ubiqui-
tous presence of cytosolic enzymes (ARH1 and PARG) that efﬁ-
ciently reverse mono- and poly-ADP-ribosylation.
SIRT2 regulates adipocyte differentiation by deacetylation of
FOXO1 in the cytosol [56]. Moreover, it was identiﬁed as a tubulin
deacetylase [57] and thereby contributes to the regulation of
microtubule-associated functions.
An unresolved problem has been the generation of NAD+/
NADP+-derived calcium messengers in the cytosol. All these mes-
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of cytosolic calcium and are known to act at the cytosolic side of
calcium channels present in organellar or the plasma membranes.
While ADPR and OAADPR originate from reversible ADP-ribosyla-
tion or NAD+-dependent protein deacetylation, respectively, the
pathway of how cADPR and NAADP arise in the cytosol has re-
mained unclear. Both known mammalian NADases, CD38 and
CD157, are ecto-enzymes and no other candidate enzyme that
might catalyse the synthesis of these messengers in the cytosol
has been identiﬁed. Therefore, transport mechanisms have been
invoked which could mediate, for example, the entry of cADPR
from the extracellular space or through the membranes of endo-
somes following internalization of CD38. Irrespective of these
uncertainties, cytosolic calcium signalling mediated by NAD+/
NADP-derived messengers has been intensely studied and demon-
strated in a multitude of model systems: Secretory functions of
pancreatic acinar cells are coordinated by NAADP and cADPR, T cell
activation relies on successive cytosolic calcium elevations trig-
gered by different messengers, and in the brain, the regulation of
TRPM2 channels by NAD+-derived ligands is crucial.
3.4. Mitochondrial NAD+-dependent signalling
While mitochondria had been largely regarded as purely meta-
bolic and bioenergetic workhorses, research over the last decades
identiﬁed these organelles as key players in central regulatory
mechanisms. It is now clear that NAD+-mediated signalling within
these organelles plays a fundamental role in metabolic regulation.
Key components of the respiratory chain, fatty acid degradation,
and ammonia detoxiﬁcation are regulated by the three mitochon-
drial sirtuins, SIRT3, SIRT4, and SIRT5 [13]. SIRT3 has been best
studied and was shown to deacetylate a number of mitochondrial
proteins including enzymes of the b-oxidation pathway, glutamate
dehydrogenase, and a subunit of complex I in the respiratory chain.
SIRT5 accelerates the urea cycle by deacetylating carbamoylphos-
phate synthase 1, the rate-limiting enzyme [58]. Besides acetyla-
tion/deacetylation, glutamate dehydrogenase also appears to be
regulated by mono-ADP-ribosylation mediated by SIRT4 [59].
While the ADP-ribosylation is inhibitory, deacetylation apparently
releases the inhibition caused by the acetylation of enzymes [13].
Interestingly, the synthesis of acetyl-CoA, the substrate for protein
acetylation, is regulated by acetylation/deacetylation of acetyl-CoA
synthase (ACS). Both the cytosolic and the mitochondrial isoforms
are activated by NAD+-dependent deacetylation [60].
4. NAD+ pools and NAD+-dependent signalling
Given the multitude of NAD+-degrading activities and the dy-
namic interconversion of NAD+ and NADH, accurate determination
of NAD+ concentrations in tissues or cells, let alone subcellular
organelles, has remained difﬁcult. An additional obstacle to under-
standing the regulation of NAD+-dependent signalling pathways by
substrate availability is the uncertainty regarding free vs. protein-
bound NAD+. Therefore, so far the knowledge about ‘‘active’’ NAD+
concentrations has remained rather limited and reported numbers
often vary widely depending on the model system, the experimen-
tal conditions, and the method of nucleotide determination. Never-
theless, there are several interesting observations regarding the
relationship of NAD+ pools and NAD+-consuming processes
(Fig. 2). Reported NAD+ concentrations in tissues are most often
in the submillimolar range [4]. Generally, the mitochondrial
NAD+ concentration appears to be higher than that measured for
whole cells or tissues. Therefore, mitochondria maintain a high
NAD+ concentration. Accordingly, tissues with a high content of
mitochondria (e.g., heart or liver) tend to have higher NAD+ con-
tents. In mammals, the mitochondrial NAD+ pool is segregatedfrom the cytosol. NAD+ exchange over the inner mitochondrial
membrane has been discovered in plant and yeast mitochondria
[61,62], but not in animals.
Even though conclusive experimental evidence is lacking (and
very hard to obtain), the cytosolic and nuclear NAD+ pools are most
often considered to be readily exchangeable. Therefore, it is gener-
ally assumed that the nuclear and cytosolic NAD+ concentrations
are similar. Whether these are valid suppositions remains to be
seen. Interestingly, the known subcellular distribution of NAD+-
dependent signalling mechanisms coincides with the established
presence of NAD+ in these compartments. The biochemical func-
tions of peroxisomes (e.g., fatty acid oxidation) also imply the pres-
ence of NAD+ in these organelles. Indeed, in a recent report the
presence of NAD+ in peroxisomes was visualized [63]. Surprisingly,
this study also established that the endoplasmic reticulum and the
Golgi complex constitute NAD+ pools that are likely independent of
the cytosolic one. However, so far there is no information regarding
the NAD+ concentration in these compartments (as indicated by
their grey shading in Fig. 2), nor whether their NAD+ pools also par-
ticipate in regulatory processes.
The versatility of NAD+ conversions in the extracellular space is
in apparent contradiction to the rather low NAD+ concentration
measured in extracellular ﬂuids (e.g., submicromolar in plasma,
see Fig. 2). It is conceivable that the overall concentration may re-
ﬂect an average of high local concentrations and an otherwise
nearly complete absence of NAD+ in extracellular ﬂuids. That is,
spatially conﬁned release of NAD+ may have paracrine function
or signal cell damage to alert repair systems.
5. Perspectives
NAD+ has emerged as an important mediator of signalling both
between and within cells. This nucleotide undergoes a variety of
conversions leading to protein modiﬁcations or activation of ion
channels with pronounced physiological effects both on the cellu-
lar and organismal level. The consumption of NAD+ by different en-
zymes necessitates continuous resynthesis of the molecule. How
NAD synthesis and consumption are affected by the subcellular
localization of the enzymes participating in NAD+-synthesis and
NAD+-conversion, and how the supply of NAD+ to different cellular
compartments is organized remain challenging questions. New re-
search tools including speciﬁc antibodies, agonists, and antagonists
directed against the key enzymes of NAD+ synthesis and consump-
tion will help address these questions. Moreover, these reagents
may pave the way to a new generation of therapeutics for treating
metabolic and inﬂammatory diseases in which NAD+ signalling is
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